Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
NCT01465347
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma
GBM
Glioma
Interventions
DRUG:
Trans Sodium Crocetinate (TSC)
Sponsor
Diffusion Pharmaceuticals Inc